Catherine Moukheibir Ironwood Pharmaceuticals Inc (IRWD) insider trading activity

Catherine Moukheibir is of IRONWOOD PHARMACEUTICALS INC. Currently has a direct ownership of 72,944 shares of IRWD, which is worth approximately $495,289. The most recent transaction as insider was on Jun 18, 2024, when has been sold 24,311 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.9K

43.29% 3M change

41.63% 12M change

Total Value Held $495,289

Catherine Moukheibir Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2024	BUY Grant, award, or other acquisition	-	24,311 Added 25.0%	72,944 Class A Common Stock
Jun 07 2024	SELL Open market or private sale	$235,144 $6.61 p/Share	35,574 Reduced 42.25%	48,633 Class A Common Stock
Jun 06 2024	SELL Open market or private sale	$282,549 $6.36 p/Share	44,426 Reduced 34.54%	84,207 Class A Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	-	1,572 Added 1.21%	128,633 Class A Common Stock
Sep 15 2023	BUY Grant, award, or other acquisition	-	2,098 Added 1.62%	127,061 Class A Common Stock
Jun 20 2023	BUY Grant, award, or other acquisition	-	22,350 Added 15.17%	124,963 Class A Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	1,586 Added 1.52%	102,613 Class A Common Stock

Mar 15 2023	BUY Grant, award, or other acquisition	-	1,677 Added 1.63%	101,027 Class A Common Stock
Jun 01 2022	BUY Grant, award, or other acquisition	-	21,571 Added 17.84%	99,350 Class A Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	1,466 Added 1.85%	77,779 Class A Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	1,541 Added 1.98%	76,313 Class A Common Stock
Sep 15 2021	BUY Grant, award, or other acquisition	-	1,447 Added 1.9%	74,772 Class A Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	1,565 Added 2.09%	73,325 Class A Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	22,766 Added 24.08%	71,760 Class A Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	1,573 Added 3.11%	48,994 Class A Common Stock

Also insider at

MLTX

MoonLake Immunotherapeutics Healthcare

Director